Avantor Research and Development Expense (TTM) Analysis

Avantor, Inc. (AVTR)

14.94 +0.28 (+1.95%) USD | NYSE | Sep 03, 14:14

View Research and Development Expense (TTM) for AVTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Research and Development Expense (TTM) Chart

Start Trial

View and export this data back to . Start Trial.

Date	Value

R&D expense is a line item from many companies' income statements.

View Research and Development Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Research and Development Expense (TTM) Benchmarks

Start Trial

Medpace Holdings, Inc.	--
Champions Oncology, Inc.	9.084M
Personalis, Inc.	56.12M
Adaptive Biotechnologies Corp.	80.01M
10X Genomics, Inc.	226.80M